These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29305275)

  • 121. Moyamoya syndrome associated with Graves' disease: a case series study.
    Ni J; Zhou LX; Wei YP; Li ML; Xu WH; Gao S; Cui LY
    Ann Transl Med; 2014 Aug; 2(8):77. PubMed ID: 25333052
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Moyamoya disease: A retrospective study of 198 cases.
    Ma Y; Guo Q; Yan Y; Zhang Y; Lin Z; Zhang J; Wang K; Song C
    Med Clin (Barc); 2019 Dec; 153(12):441-445. PubMed ID: 31182226
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Moyamoya disease in a European setting: a Danish population-based study.
    Birkeland P; Tharmabalan V; Lauritsen J; Ganesan V; Bjarkam CR; von Weitzel-Mudersbach P
    Eur J Neurol; 2020 Dec; 27(12):2446-2452. PubMed ID: 32668488
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Moyamoya-like vasculopathy associated to MYH9-related thrombocytopenia manifested by multiple cerebral ischemic lesions: a case report.
    Ribigan AC; Badea RS; Ciocan A; Stefan D; Casaru B; Ioan P; Antochi F; Băjenaru O
    BMC Neurol; 2020 Sep; 20(1):352. PubMed ID: 32950057
    [TBL] [Abstract][Full Text] [Related]  

  • 125. An Interesting Case of Moyamoya Disease, a Rare Cause of Transient Ischemic Attacks.
    Sapra A; Bhandari P; Dix R; Sharma S; Ranjit E
    Cureus; 2020 Aug; 12(8):e9736. PubMed ID: 32944454
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Moyamoya disease. Report of three cases in Brazilian patients.
    Franco CM; Fukujima MM; de Oliveira Rde M; Gabbai AA
    Arq Neuropsiquiatr; 1999 Jun; 57(2B):371-6. PubMed ID: 10450341
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children.
    Kurokawa T; Tomita S; Ueda K; Narazaki O; Hanai T; Hasuo K; Matsushima T; Kitamura K
    Pediatr Neurol; 1985; 1(5):274-7. PubMed ID: 3880414
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Moyamoya disease in a child with glycogen storage disease type Ia.
    Goutières F; Bourgeois M; Trioche P; Demelier JF; Odievre M; Labrune P
    Neuropediatrics; 1997 Apr; 28(2):133-4. PubMed ID: 9208417
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Thyroid autoantibodies in aborigines.
    Barbato MP; Agar NS; Kirk RL
    Med J Aust; 1980 May; 1(11):543-5. PubMed ID: 7393039
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review.
    Kleinloog R; Regli L; Rinkel GJ; Klijn CJ
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):531-6. PubMed ID: 22378916
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Visual Hallucinations in a Patient With Moyamoya Disease: A Review and Case Report.
    Bodoano Sánchez I; Fernández-Pérez MD; Molera Manzano D; Gutiérrez-Rojas L; Romero-Fábrega JC
    Cogn Behav Neurol; 2021 Mar; 34(1):63-69. PubMed ID: 33652470
    [TBL] [Abstract][Full Text] [Related]  

  • 132. The maya behind moyamoya--the two extremes of the disease.
    Vijayakanthi N; Natarajan T
    Indian J Pediatr; 2013 Jul; 80(7):601-3. PubMed ID: 22733293
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Neuroradiologic correlates of cognitive impairment in adult Moyamoya disease.
    Mogensen MA; Karzmark P; Zeifert PD; Rosenberg J; Marks M; Steinberg GK; Dorfman LJ
    AJNR Am J Neuroradiol; 2012 Apr; 33(4):721-5. PubMed ID: 22173751
    [TBL] [Abstract][Full Text] [Related]  

  • 134. SEREX identification of the autoantibodies that are prevalent in the cerebrospinal fluid of patients with moyamoya disease.
    Kim J; Kim SK; Wang KC; Kim HY; Jeoung D
    Biotechnol Lett; 2004 Apr; 26(7):585-8. PubMed ID: 15168859
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version.
    Kuroda S; Fujimura M; Takahashi J; Kataoka H; Ogasawara K; Iwama T; Tominaga T; Miyamoto S;
    Neurol Med Chir (Tokyo); 2022 Jul; 62(7):307-312. PubMed ID: 35613882
    [TBL] [Abstract][Full Text] [Related]  

  • 136. A cerebrospinal fluid protein associated with moyamoya disease: report of three cases.
    Hojo M; Hoshimaru M; Miyamoto S; Taki W; Kikuchi H; Hashimoto N
    Neurosurgery; 1999 Jul; 45(1):170-3; discussion 173-4. PubMed ID: 10414582
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Moyamoya syndrome presenting in an adult with Down syndrome: A case report with a literature review.
    Hamid M; Cherradi S; Bourazza A
    Radiol Case Rep; 2022 Aug; 17(8):2798-2801. PubMed ID: 35677704
    [TBL] [Abstract][Full Text] [Related]  

  • 138. A Case Report of Moyamoya Disease Presenting as Headache in a 35-year-old Hispanic Man.
    Azzam DB; Sharma AN; Tiourin E; Chan AY
    Cureus; 2019 Apr; 11(4):e4426. PubMed ID: 31245213
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor.
    Takahashi A; Sawamura Y; Houkin K; Kamiyama H; Abe H
    Neurosci Lett; 1993 Oct; 160(2):214-6. PubMed ID: 8247356
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Neurology-Psychiatry Interface: Uncommon Presentation of Moyamoya Disease.
    Singh S; Hooda P; Singh N; Shekhawat L
    J Neurosci Rural Pract; 2019 Jul; 10(3):526-528. PubMed ID: 31595128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.